Abiopharma

InspireMD to Announce Second Quarter 2026 Financial Results

IN8bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Plug Reports Revenue of ~$178 Million, ~Break-Even Gross Margin, Net Cash Usage of ~$61 Million and Increases Revenue Guidance for 2026

NVIDIA Partners With Apollo, BlackRock, Blackstone, Brookfield, Goldman Sachs and KKR to Establish AI Compute Infrastructure Financing Platforms to Mobilize Over $500 Billion of Third-Party Capital

AirJoule Technologies Schedules Release of Second Quarter 2026 Results and Conference Call

MySize Announces Reverse Stock Split

Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2026

Lakefront Biotherapeutics rapporteert halfjaarcijfers 2026 en geeft een update over de activiteiten